Target intelligence / Profile preview

Joint sensory nerve nociceptor

Molecular classification
Ion channel, G protein-coupled receptor, Receptor, Other
01

Overview

Joint sensory nerve endings, specifically nociceptors, are specialized peripheral neurons that innervate joint structures such as the capsule, ligaments, and synovium to detect noxious stimuli (Schaible, 2014). These endings express a variety of molecular transducers, including transient receptor potential (TRP) channels, acid-sensing ion channels (ASICs), and voltage-gated sodium channels, which convert mechanical and chemical signals into action potentials (McDougall, 2006). In chronic joint diseases like osteoarthritis, these nociceptors become sensitized by inflammatory mediators such as nerve growth factor (NGF) and prostaglandins, leading to increased pain sensitivity or hyperalgesia (Miller et al., 2014). Pharmacological targeting of these sites involves the use of local anesthetics to block signal transmission, capsaicin to desensitize receptors, or monoclonal antibodies to inhibit sensitizing factors like NGF. However, profound inhibition of these nociceptive pathways can lead to safety concerns, including the risk of accelerated joint destruction due to the loss of protective pain feedback.

Other names
General nociceptor-related sites on joint sensory nerve endingsJoint nociceptorsArticular nociceptorsJoint sensory nerve endingsNociceptive afferents in joints
02

Mechanism of action

Inhibition of voltage-gated sodium channels to block nerve conduction, desensitization of TRPV1 channels, and neutralization of nerve growth factor (NGF) to prevent peripheral sensitization.

03

Biological functions

Signal transductionNociceptionMechanotransductionOther
04

Disease associations

InflammationOsteoarthritisRheumatoid arthritisChronic painOther
05

Safety considerations

Rapidly progressive osteoarthritis (RPOA)Charcot-like arthropathySystemic local anesthetic toxicityLoss of protective sensation
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

Visual Analog Scale (VAS)Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)Quantitative Sensory Testing (QST)

Beyond the preview

Go deeper on Joint sensory nerve nociceptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Joint sensory nerve nociceptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call